サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バイオ医薬品サードパーティロジスティクスの市場規模、シェア、動向分析レポート：サプライチェーン別、サービスタイプ別、地域別、セグメント予測：2023年～2030年
市場調査レポート
商品コード
1321325

バイオ医薬品サードパーティロジスティクスの市場規模、シェア、動向分析レポート：サプライチェーン別、サービスタイプ別、地域別、セグメント予測：2023年～2030年

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオ医薬品サードパーティロジスティクスの市場規模、シェア、動向分析レポート：サプライチェーン別、サービスタイプ別、地域別、セグメント予測：2023年～2030年
出版日: 2023年07月03日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品3PL市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のバイオ医薬品サードパーティロジスティクス（3PL）市場規模は2030年までに1,985億米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 6.0％で拡大すると予測されています。様々な地域で生物製剤を輸送するための温度管理された物流サービスに対する需要が増加していることや、バイオ医薬品企業の販売力向上のための流通網が拡大していることが、市場成長を促進する要因となっています。新興国における自動保管・検索システムの採用の高まりは、製薬ロジスティクス企業の間で進行中の動向であり、大きな牽引力となっています。

さらに、低分子医薬品からワクチンや生物製剤を中心とするバイオ医薬品への移行動向も市場を牽引すると予測されます。これらの低分子医薬品は温度に敏感な製品であるため、温度管理された輸送・保管の需要が高まり、市場成長の要因となっています。技術的進歩は市場成長を促進する主な要因の一つです。モバイル・クラウド・ソリューション、倉庫ロボット工学、データマイニングなどの技術は、3PL空間全体を変えてきました。これらの先端技術の助けを借りて、3PL企業は輸送中に製品に必要な温度を維持することができます。

これにより、製品の複雑さや人的ミスを減らすことができます。ほとんどのバイオ医薬品は非常に温度に敏感であるため、必要な温度で保管する必要があります。このような製品には、配送まで監視するための追跡装置が必要です。例えば、2023年5月、Tridentify社は、コールドチェーンで輸送される製品の安定性と残存賞味期限を継続的に追跡する革新的な機能を備えたリアルタイムコールドチェーンモニタリングシステムを発売しました。このシステムは、医薬品の安定性と残存賞味期限をリアルタイムで詳細に把握できるため、企業の業務監視と安定性予算の管理方法に革命をもたらすと思われます。

さらに、環境への配慮とコストにより、商業製品の輸送手段は、航空輸送から海上輸送へ、道路輸送はトラックから複合一貫輸送（鉄道とトラックの両方）へと、少しずつシフトしています。複合一貫輸送は、二酸化炭素排出量を削減するために、これらの製薬会社が主に利用しています。現在進行中の動向は、製薬メーカーがコストとリスク要因を削減するために海上輸送にシフトしていることを示しています。コールドチェーン製品については、各社は依然として航空輸送を好んでいます。しかし、一部の大手製薬会社は、コールドチェーン製品を含め、製品の70%を海上輸送で輸送することを計画しています。

バイオ医薬品3PL市場レポートハイライト

  • 2022年、非コールドチェーン・ロジスティクス分野は、温度管理を必要としない医薬品の販売数が多いことから、売上高で79.7%の最大シェアを占めました。
  • コールドチェーンロジスティクス分野は、細胞療法、ワクチン、検査キットなどの生物製剤の需要により、予測期間中にCAGR 8.8%を記録すると予想されます。
  • 倉庫・保管分野は2022年に43.3%の最大シェアを占めました。輸送分野も、企業内部の能力不足により、2022年に大きな収益シェアを占めました。
  • 北米は、バイオ医薬品の輸出入の増加により、2022年には42%以上の最大の収益シェアを占めました。
  • アジア太平洋地域は、高齢化による医薬品の採用と、ブランドメーカーからジェネリックメーカーへの医薬品販売の移行により、予測期間中に7.4%のCAGRを記録すると予想されます。
  • 主要企業は、市場での存在感を高めるためにいくつかの戦略的な取り組みを行っています。例えば、2021年2月、Kuehne+Nagelは中国最大の非国営医薬品流通企業Jointownとパートナーシップを締結し、中国におけるヘルスケア＆医薬品ロジスティクスの足跡を強化しています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報またはデータ分析
  • 調査手法
  • 調査範囲と前提条件
  • 市場の形成と検証
  • 国別セグメントシェアの計算
  • データソースのリスト

第2章 エグゼクティブサマリー

第3章 バイオ医薬品サードパーティロジスティクス市場の変数、動向、および範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • バイオ医薬品サードパーティロジスティクス市場分析ツール
    • 業界分析- ポーター
    • PESTEL分析

第4章 バイオ医薬品サードパーティロジスティクス市場：サービスタイプの推定・動向分析

  • セグメントダッシュボード
  • バイオ医薬品サードパーティロジスティクス市場：サービス変動分析、10億米ドル、2022年および2030年
  • 交通機関
    • 交通市場収益推計と予測、2018～2030年
    • 航空貨物
    • 海上輸送貨物
    • 陸上輸送
  • 倉庫と保管
    • 倉庫およびストレージ市場収益推計と予測、2018～2030年
  • その他
    • その他の市場収益推計と予測、2018～2030年

第5章 バイオ医薬品サードパーティロジスティクス市場：サプライチェーンの推定・動向分析

  • セグメントダッシュボード
  • バイオ医薬品サードパーティロジスティクス市場：サプライチェーン変動分析、10億米ドル、2022年および2030年
  • コールドチェーン
    • コールドチェーン市場収益推計と予測、2018～2030年
  • 非コールドチェーン
    • 非コールドチェーン市場収益推計と予測、2018～2030年

第6章 バイオ医薬品サードパーティロジスティクス市場：地域別の推定・動向分析

  • バイオ医薬品サードパーティロジスティクス市場：地域変動分析、2022年および2030年
  • 北米
    • 北米医薬品サードパーティ物流市場推計・予測、2018年から2030年
    • 規制の枠組み
    • 米国
    • カナダ
  • 欧州
    • 欧州のバイオ医薬品サードパーティロジスティクス市場推計・予測、2018年から2030年
    • 規制の枠組み
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域のバイオ医薬品サードパーティロジスティクス市場推計・予測、2018年から2030年
    • 規制の枠組み
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのバイオ医薬品サードパーティロジスティクス市場推計・予測、2018年から2030年
    • 規制の枠組み
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 中東およびアフリカのバイオ医薬品サードパーティロジスティクス市場推計・予測、2018年から2030年
    • 規制の枠組み
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 企業の市場シェア分析、2022年
  • 主要民間企業リスト
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • DHL International GmbH
    • SF Express
    • United Parcel Service of America, Inc.
    • AmerisourceBergen Corp.
    • DB Schenker
    • Kuehne and Nagel
    • Kerry Logistics Network Ltd.
    • Agility
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 4. Global Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 5. Global Biopharmaceutical Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
  • Table 6. North America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 7. North America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 8. North America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 9. U.S. Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 10. U.S. Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 11. Canada Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 12. Canada Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 13. Europe Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 14. Europe Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 15. Europe Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 16. Germany Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 17. Germany Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 18. UK Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 19. UK Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 20. France Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 21. France Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 22. Italy Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 23. Italy Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 24. Spain Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 25. Spain Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 26. Denmark Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 27. Denmark Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 28. Sweden Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 29. Sweden Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 30. Norway Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 31. Norway Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 32. Asia Pacific Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 33. Asia Pacific Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 35. China Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 36. China Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 37. Japan Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 38. Japan Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 39. India Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 40. India Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 41. South Korea Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 42. South Korea Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 43. Australia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 44. Australia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 45. ThailandBiopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 46. ThailandBiopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 47. Latin America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 48. Latin America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 49. Latin America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 50. Brazil Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 51. Brazil Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 52. Mexico Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 53. Mexico Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 54. Argentina Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 55. Argentina Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 59. South Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 60. South Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 63. UAE Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 64. UAE Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 65. Kuwait Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 66. Kuwait Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Primary Research Pattern
  • Fig. 2 Market Research Approaches
  • Fig. 3 Value Chain-Based Sizing & Forecasting
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Biopharmaceutical Third-party Logistics Market, Market Segmentation
  • Fig. 6 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 9 Penetration & Growth Prospect Mapping
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biopharmaceutical Third-party Logistics Market for Cold chain, 2018 - 2030 (USD Billion)
  • Fig. 15 Global Biopharmaceutical Third-party Logistics Market for Non-cold chain, 2018 - 2030 (USD Billion)
  • Fig. 16 Global Biopharmaceutical Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Biopharmaceutical Third-party Logistics Market for Air freight, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Biopharmaceutical Third-party Logistics Market for Sea freight, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Biopharmaceutical Third-party Logistics Market for Overland transportation, 2018 - 2030 (USD Billion)
  • Fig. 20 Global Biopharmaceutical Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
  • Fig. 21 Global Biopharmaceutical Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
  • Fig. 22 Regional Outlook, 2021 & 2030
  • Fig. 23 North America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Europe Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Germany Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 28 UK Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 29 France Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 30 Italy Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Spain Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Denmark Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Sweden Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Norway Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Asia Pacific Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Japan Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 37 China Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 38 India Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Australia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 40 South Korea Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Thailand Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Latin America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Brazil Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Mexico Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-2-68038-773-5

Biopharmaceutical 3PL Market Growth & Trends

The global biopharmaceutical third-party logistics (3PL) market size is expected to reach USD 198.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030. Increasing demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend among pharmaceutical logistics companies that has gained significant traction.

Furthermore, the trend of shifting from small-molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus, is responsible for the market growth. Technological advancements are among the main factors drivingmarket growth. Technologies, such as mobile cloud solutions, warehouse robotics, and data mining, have changed the overall 3PL space. With the help of these advanced technologies, 3PL companies can maintain the required temperatures for products during transportation.

This will help in reducing complexities in products and human errors. Most biopharmaceutical products are very temperature-sensitive and hence should be stored at the required temperatures. These products require a tracking device for monitoring until delivery. For instance, in May 2023, Tridentify launched a real-time cold chain monitoring system with an innovative feature for continuously tracking the stability and remaining shelf life of products transported in the cold chain. It offers a thorough view of the stability and remaining shelf-life of pharmaceutical products in real-time, which will revolutionize the way companies monitor their operations and manage their stability budgets.

In addition, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck) transport. Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted to sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Biopharmaceutical 3PL Market Report Highlights

  • In 2022, the non-cold chain logistics segment held the largest share of 79.7% in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is expected to register a CAGR of 8.8% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The warehousing and storage segment held the largest share of 43.3% in 2022. The transportation segment also held a significant revenue share in 2022 due to the lack of internal capabilities of companies
  • North America held the largest revenue share of over 42% in 2022 owing to the rise in imports and exports for biopharmaceutical in the country
  • Asia Pacific is expected to register the fastest CAGR of 7.4% over the forecast period owing to the adoption of medicines from the aging population and the shift of drug sales from brand manufacturers to generic
  • The key players are undertaking several strategic initiatives to strengthen their market presence. For instance, in February 2021, Kuehne+Nagel entered into a partnership with China's largest non-state-owned pharma distribution company, Jointown, to enhance its footprint in healthcare & pharmaceutical logistics in China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
    • 1.6.1. COUNTRY MARKET: CAGR CALCULATION
  • 1.7. Country Based Segment Share Calculation
  • 1.8. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional Insights
  • 2.4. Competitive Insights
  • 2.5. Biopharmaceutical Third Party Logistics Market Snapshot
  • 2.6. Biopharmaceutical Third Party Logistics Market Segment Snapshot
  • 2.7. Biopharmaceutical Third Party Logistics Market Competitive Landscape Snapshot

Chapter 3. Biopharmaceutical Third Party Logistics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Biopharmaceutical Third-party Logistics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Biopharmaceutical Third-party Logistics Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis, USD Billion, 2022 & 2030
  • 4.3. Transportation
    • 4.3.1. Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2. Air Freight
      • 4.3.2.1. Air Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.3. Sea Freight
      • 4.3.3.1. Sea Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.4. Overland Transportation
      • 4.3.4.1. Overland Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Warehousing & Storage
    • 4.4.1. Warehousing & Storage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis, USD Billion, 2022 & 2030
  • 5.3. Cold Chain
    • 5.3.1. Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Non-Cold Chain
    • 5.4.1. Non-Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceutical Third Party Logistics Market: Regional Movement Analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Regulatory Framework
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. U.S. Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Canada Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. Regulatory Framework
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. UK Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Germany Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. France Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Italy Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Spain Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Denmark Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Sweden Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Competitive Scenario
      • 6.3.10.3. Norway Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Regulatory Framework
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Japan Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. China Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. India Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Australia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Thailand Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. South Korea Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Regulatory Framework
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Brazil Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Mexico Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Argentina Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Regulatory Framework
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. South Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Saudi Arabia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. UAE Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Kuwait Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Share Analysis, 2022
  • 7.3. List of Key Private Players
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. DHL International GmbH
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. SF Express
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. United Parcel Service of America, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AmerisourceBergen Corp.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. DB Schenker
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Kuehne and Nagel
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Kerry Logistics Network Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Agility
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives